Patient-reported outcomes with direct-acting antiviral treatment for hepatitis C in West and Central Africa (TAC ANRS 12311 trial)

BACKGROUND & AIMS: Patient-reported outcomes (PROs) are poorly documented for patients with chronic hepatitis C on direct-acting antiviral (DAA) treatment in low-to-middle-income countries. We documented PROs during and after DAA treatment in participants of the TAC ANRS 12311 trial (West and Ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Marcellin, Fabienne, Mourad, Abbas, Lemoine, Maud, Kouanfack, Charles, Seydi, Moussa, Carrieri, Patrizia, Attia, Alain, Protopopescu, Camelia, Lacombe, Karine, Boyer, Sylvie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9853347/
https://www.ncbi.nlm.nih.gov/pubmed/36686592
http://dx.doi.org/10.1016/j.jhepr.2022.100665

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9853347/
https://www.ncbi.nlm.nih.gov/pubmed/36686592
http://dx.doi.org/10.1016/j.jhepr.2022.100665

Ejemplares similares